ACTD: BRIDGE BETWEEN REGULATORY REQUIREMENTS OF DEVELOPED AND DEVELOPING COUNTRIES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2013, Vol 1, Issue 4
Abstract
Regulatory Dossier contains data which when submitted to the regulatory authority, provides for the review and ultimate approval of a drug product. Once approved, an applicant may manufacture and market the drug to provide a safe, effective and low cost which benefits the society. Filing requirements in developed countries differ from developing countries which makes the approval process tedious and time consuming for the later. To make this process smooth, ASEAN CTD (ACTD) was developed by Association of South East Asian Nations (ASEAN) nations. As format of ACTD resembles the format of Common Technical Document (CTD) with some differences, hence it can be used as a step. Also if both guidelines can be harmonized then differences and variation between both the guidelines can be minimized. This article focuses on the similarities and differences in between CTD & ACTD and highlights how ACTD can be a initiating step for developing countries to meet pharmaceutical regulations of developed countries.
Authors and Affiliations
Jain Achin, Venkatesh M P, Pramod Kumar T M
Keywords
Related Articles
- EP ID EP338247
- DOI -
- Views 95
- Downloads 0
Regulation of Blood and Blood products in India, USA and EU
Blood and blood products are precious commodity which gives life to another person. Though we have immense discoveries and invention in science and technology, yet we cannot make blood hence, human blood has no substitut...
SIMULTANEOUS UV SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF CEFADROXIL AND PROBENECID IN TABLET DOSAGE FORM
Two methods for simultaneous estimation of Cefadroxil and Probenecid in combined tablet dosage form have been developed. The first UV spectrophotometric method was a determination using the simultaneous equation method a...
THE NEW REGULATIONS FOR THE APPROVAL OF MEDICINAL PRODUCTS IN IVORY COAST: APPLICATION OF REGULATION N ° 06/2010 / CM / WAEMU RELATING TO PROCEDURES FOR THE APPROVAL OF PHARMACEUTICAL PRODUCTS FOR HUMAN USE IN WAEMU MEMBER STATES
Harmonization of procedures for the approval of medicines in the WAEMU area allows Member States to have a standard tool for the examination of applications for marketing authorization for medicinal products for human us...
SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE
In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different reg...
QUALITY BY DESIGN- A NEW APPROACH TO DRUG DEVELOPMENT
Quality by design is an essential part of the modern approach to pharmaceutical quality. A new approach to drug development could increase efficiencies, provide regulatory relief and flexibility, and offer important busi...